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Malignant melanoma is an increasingly common condition in young women.' If
pregnancy occurs, the prognosis for the tumour may be adversely affected.
Clinicians should be constantly aware of these tumours and the possible effect on
prognosis by a concurrent pregnancy.
CASE HISTORY
A 32-year-old primagravida with no significant past medical history attended for
booking at 13 weeks' amenorrhoea. She had used a combined oral contraceptive
pill for four years until approximately six months prior to conception. She smoked
10 cigarettes per day. She received shared antenatal care which was uneventful
until the spontaneous onset of labour at 38 weeks' gestation. After a seven-hour
labour with epidural anaesthesia she had a vacuum extraction of a live male infant
weighing 2835g. On the first day of the puerperium, routine examination of the
patient revealed a 1-cm-diameter pigmented lesion on the lateral aspect of the
left lower calf. On further enquiry this lesion had been present for many years but
during the pregnancy it had enlarged slightly. There was no associated irritation,
pain nor bleeding. This lesion was clinically suspicious of a malignant melanoma.
There was no lymphadenopathy, hepatomegaly nor bony tenderness and the
lung fields were clinically normal.
On the fourth post-partum day, excisional biopsy was carried out under general
anaesthesia, and histology revealed a malignant melanoma. On the sixth post-
partum day, the site of the lesion was widely excised and the defect covered by a
split skin graft from the right thigh. Prophylactic heparin, 5000 IU twice daily, was
administered until the patient was fully mobile. Histological examination revealed
a malignant melanoma 0.5cm x 0.75cm with no spread within the limits of
the specimen. The tumour extended to the level of the recticular dermis
corresponding to Clarke Level 3. Chest X-ray, liver function tests and bio-
chemical bone profile were all normal. Prophylactic groin lymph node biopsy was
not performed but computerised tomography ofthe groin and pelvic lymph nodes
was normal. The placenta was disposed of prior to the diagnosis of melanoma
and, though macroscopically normal, was not subjected to histological
examination.
DISCUSSION
During pregnancy, melatonin (MSH) is markedly raised, leading to the well -
known pigmentation of pregnancy. However, the effect of pregnancy on a
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pre-existing melanoma is not clear, with conflicting evidence in the literature.
Houghton has shown no significant alteration in the prognosis,2 whereas Shiu
found a significant worsening due to pregnancy only in Stage 11 disease where
regional lymph nodes were involved.3 Eleven studies were reviewed in detail by
Holly, who found overall no survival difference related to pregnancy in females
with malignant melanoma.4 In fact, Hersey et al demonstrated a better survival in
parouswomenwhencompared with nulliparous controls.5Treatmentofmalignant
melanoma remains primarily surgical, which in pregnancy is complicated by the
risks ofdeep vein thrombosis and aspiration pneumonitis ifgeneral anaesthesia is
used. Hormone manipulation, termination ofpregnancy, oophorectomy, adrenal-
ectomy and hypophysectomy have not been shown to be of any benefit.
Freedman and MacMahon have shown that metastasis to the placenta and the
fetus, fortunately, is rare.6
With regard to future pregnancies, Shiu would discourage pregnancy in patients
with a history of Stage II disease or those with previous activation of the lesion
during pregnancy.3 Recent reviews of this literature conclude that subsequent
pregnancy has little if any adverse effect upon recurrence or survival rates.78
Finally, should these patients use combined oral contraceptives because of the
possible adverse effects of any oestrogen components? Early reports were
conflicting, and recent case control studies9 have shown no increase in risk with
combined oral contraception, suggesting there may be a protective effect in some
age groups. There is no advice available on the use of progesterone only
contraceptive medication.
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